Biofeedback training to improve vision in glaucoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial that will enroll 70 adults with glaucoma and paracentral scotomata and assign them 1:1 to either five weekly biofeedback training sessions or a control group receiving standard assessments. The intervention uses visual and auditory feedback during microperimetry to train eye movements toward retinal areas with better sensitivity and stability, with each session lasting about 20 minutes. Outcomes including fixation stability, retinal sensitivity, visual acuity, reading speed, contrast sensitivity, and vision-related quality of life will be measured at baseline and follow-up visits. The control group will be offered the training after completion of their study participation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18-95 years old.
* Glaucoma cases with adequate intraocular pressure control.
* Presence of paracentral scotomata within two degrees of fixation.
* Ability to follow instructions for biofeedback training.

Exclusion Criteria:

* Prior or current low vision rehabilitation treatment.
* Ocular diseases or severe clinical conditions unrelated to glaucoma
* Media opacities that prevent reliable microperimetry testing in both eyes.
* Inability to perform study assessments or follow instructions for biofeedback training.

Where it's running

• University Health Network/ Toronto Western Hospital
  Toronto, Ontario, Canada Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Balance training for people with glaucoma

  A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.

  Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Küçükçekmece, Istanbul · NCT07910955

• Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma

  In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.

  Recruiting Phase 4 Indiana University · Bloomington, Indiana · NCT07847073

• Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients

  This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.

  Recruiting Tomey Corporation · Jacksonville, Florida · NCT07804277

• Removing the ripcord from a glaucoma drainage device after 3 months

  This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.

  Recruiting Duke University · Durham, North Carolina · NCT07803536

• Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing

  This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.

  Recruiting University Hospital, Bordeaux · Bordeaux · NCT07802769

• Long-Term Results After Ab-interno Trabeculotomy for Glaucoma

  This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.

  Recruiting Wuerzburg University Hospital · Würzburg, Bavaria · NCT07780916

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.